Details of Disease

General Information of Disease (ID: DISPKUD1)

• Disease Name: Seasonal influenza infection
• Disease Class: 1E30-1E32: Influenza
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DISPKUD1: Seasonal influenza infection
• ICD Code:
  ICD-11: ICD-11: 1E30
  ICD-9: ICD-9: 487
  Expand ICD-9: 487
• Disease Identifiers:
  MONDO ID: MONDO_0005812
  MESH ID: D007251
  UMLS CUI: C0021400
  MedGen ID: 9466
  SNOMED CT ID: 6142004

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 2 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Flu vaccine	DMB7TD8	Approved	NA	[1]
Q-LAIV	DM6EYVW	Approved	NA	[1]

This Disease is Treated as An Indication in 5 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
ASP7374	DMLCF8H	Phase 3	NA	[2]
Influenza virus vaccine quadrivalent	DMGZQWX	Phase 3	NA	[3]
Nanoflu	DMNIPPY	Phase 3	NA	[4]
NasoVAX	DM9Z2MF	Phase 2	NA	[3]
NB-1008	DM65W0F	Phase 1	NA	[5]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [2] ClinicalTrials.gov (NCT01961960) A Study to Evaluate Intramuscular ASP7374. U.S. National Institutes of Health.
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [4] ClinicalTrials.gov (NCT04120194) Phase 3 Pivotal Trial of NanoFlu in Older Adults. U.S. National Institutes of Health.
• [5] ClinicalTrials.gov (NCT01354379) Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer. U.S. National Institutes of Health.